A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation
Clinical trial NCT01459926 · COMPLETED
Trial details
- NCT number
- NCT01459926
- Sponsor
- Glycyx Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.